Literature DB >> 7989269

Regulatory effects of bifidobacteria on the growth of other colonic bacteria.

G R Gibson1, X Wang.   

Abstract

In the human large intestine bifidobacteria are a numerically important group of micro-organisms which are considered to exert a range of biological activities related to host health. One aspect is the inhibitory effect of these bacteria on other species, possibly excluding long term colonization by invasive pathogens. It has been suggested that the mechanism of inhibition carried out by bifidobacteria is related to the fermentative production of acids such as acetate and lactate. Experiments reported in this paper attempted to address this theory. Co-culture experiments whereby Bifidobacterium infantis was incubated with Escherichia coli and Clostridium perfringens, in a variety of fermentation systems, indicated that the bifidobacterium was able to exert an inhibitory effect not necessarily related to acid production. Further studies showed that eight species of bifidobacteria could variously excrete an anti-microbial substance with a broad spectrum of activity. Species belonging to the genera Salmonella, Listeria, Campylobacter and Shigella, as well as Vibrio cholerae, were all affected. These results show that bifidobacteria are able to exert more than one mechanism of inhibition, which may be of some importance with regard to protection against gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989269     DOI: 10.1111/j.1365-2672.1994.tb03443.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  95 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  Characterization of microbial communities in gas industry pipelines.

Authors:  Xiang Y Zhu; John Lubeck; John J Kilbane
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

3.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.

Authors:  S J Langlands; M J Hopkins; N Coleman; J H Cummings
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

5.  Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine.

Authors:  Amlan Biswas; Jeanette Wilmanski; Huamei Forsman; Tomas Hrncir; Liming Hao; Helena Tlaskalova-Hogenova; Koichi S Kobayashi
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

6.  Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats.

Authors:  Suh-Ching Yang; Ju-Yen Chen; Huey-Fang Shang; Ting-Ying Cheng; Su Chen Tsou; Jiun-Rong Chen
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

7.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

Review 8.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

9.  Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.

Authors:  C Favier; C Neut; C Mizon; A Cortot; J F Colombel; J Mizon
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

10.  Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system.

Authors:  Hollie M Probert; Juha H A Apajalahti; Nina Rautonen; Julian Stowell; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.